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654.e1 The Journal of Thoracic and CarObjective: We sought to determine the incidence of and risk factors for the
development of low intraoperative hematocrit levels and of excessive postoperative
bleeding in patients undergoing coronary artery bypass grafting, whether the risk
factors are the same, and their effect on blood product transfusions.
Methods: We performed a prospective cohort study of 613 adult patients who
underwent coronary artery bypass grafting in 3 tertiary, university-affiliated hospi-
tals during the period from October 1, 2000, to March 31, 2001.
Results: Low intraoperative hematocrit levels (19%) were found in 131 (24%)
patients who had operations performed with extracorporeal circulation compared
with in 3 (4%) patients with operations performed off pump. In multivariate analysis
this was associated with older age, female sex, lower preoperative hemoglobin
levels, lower body surface area, longer duration on bypass, and use of higher total
volumes with more hydroxyethyl starch in the circuit. Low intraoperative hemato-
crit levels did not predict excessive postoperative hemorrhage (1 L of mediastinal
drainage in the first 12 hours). This occurred in 26% (n  140) of patients
undergoing on-pump operations and in 25% of patients undergoing off-pump
operations and in multivariate analysis was associated with male sex, longer pump
times, not receiving aprotinin, and operations performed by certain surgeons but not
with total circuit or hydroxyethyl starch volume.
Conclusions: We observed that the risk factors for the development of a low
intraoperative hematocrit level and excessive postoperative bleeding differed. Our
results suggest that decreasing these outcomes in patients undergoing cardiac
surgery requires a comprehensive approach, including limiting hemodilution, par-
ticularly in female subjects with lower preoperative hemoglobin levels, and careful
attention to surgical hemostasis.
Patients who undergo cardiac surgery commonly receive blood product trans-fusions, but there are substantial and unexplained differences in rates indifferent institutions.1,2 Consensus recommendations are to consider intraop-
erative transfusion of packed cells if the hematocrit level decreases to less than 19%
intraoperatively.3,4 Drainage in excess of 1 L postoperatively is associated with
accelerated transfusion of blood products in the order of greater than 5 units.2,5 Both
excessive bleeding and low hematocrit levels are common and associated with
worse outcomes,6-8 yet these have not been well characterized.2,6 Because of the
assumption that risk factors for perioperative blood product transfusions3,9,10 and for
bleeding are the same, preventive strategies have focused on agents promoting or
limiting preoperative use of agents that impair hemostasis.11-14 However, intraop-
erative anemia might be related to hemodilution, but this has received scant
attention.15-17 It is also unclear whether the substantial differences in blood product
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sion practices or protocols, intraoperative antifibrinolytic
use, surgical technique, or differences in patient popula-
tions.
After observing differences in practices in cardiac sur-
gery in the 3 affiliated hospitals at our university, we pro-
spectively evaluated the occurrence and risk factors for
excessive postoperative hemorrhage and low intraoperative
hematocrit values.
Methods
Setting and Study Population
The study was conducted in 3 general, tertiary, university-affiliated
adult hospitals. In hospital A approximately 800 cardiac surgery
procedures are performed annually by 4 surgeons, whereas in
hospitals B and C approximately 500 such procedures are per-
formed annually, primarily by 2 surgeons at each site; one surgeon
operated in both hospitals B and C. In hospital A, a total volume
of 2000 mL was used initially in the extracorporeal circuit in all
patients, 750 mL of which was hydroxyethyl starch (HES),
whereas in hospitals B and C, the total volume was 1400 mL, of
which 500 mL was HES.
None of the hospitals had written transfusion protocols. As
antifibrinolytic agents, aprotinin was routinely used in hospital A,
whereas tranexamic acid was routinely used in the other 2 hospi-
tals. During the time of the study, aprotinin was temporarily
unavailable from the manufacturer, and as a result, 46 patients in
hospital A underwent cardiac surgery without any antifibrinolytic
agent. All patients were admitted to the intensive care unit (ICU)
postoperatively, and retransfusion of shed mediastinal blood was
practiced at all sites.
Data were collected prospectively on 613 consecutive patients
who had undergone coronary artery bypass graft (CABG) proce-
dures only without any valvular operations from October 1, 2000,
to March 31, 2001, in hospitals B and C and from December 1,
2000 to March 31, 2001, in hospital A. A total of 545 procedures
were performed on pump, and 68 were performed off pump across
the 3 sites. The study was approved by the research ethics com-
mittees of the participating institutions.
Data Collection
The following data were collected from standardized data collec-
tion sheets.
Preoperative characteristics included age, sex, body surface
area, Parsonnet score,18 history of prior cardiac surgery, premorbid
diagnoses (eg, diabetes mellitus, hypertension, renal failure, coag-
ulation disorders, and left ventricular dysfunction), and whether
surgical intervention was required within 6 hours (ie, an emer-
gency procedure). We also recorded preoperative use of drugs that
impair hemostasis, such as aspirin, clopidogrel, heparin, or warfa-
rin, as well as preoperative hemoglobin level, international nor-
malized ratio, partial thromboplastin time, and platelet count.
Intraoperative factors included identity of the primary surgeon,
antifibrinolytic agent used, time on extracorporeal circulation, low-
est intraoperative hematocrit level recorded, type and number of
blood products transfused intraoperatively, highest recorded acti-
The Journal of Thoracic avated clotting time, and total number of grafts, including whether
arterial or vein grafts were used.
Postoperative factors included hemoglobin and coagulation pa-
rameters, need for exploratory reoperation, mortality, length of
stay in the ICU and length of hospitalization, mediastinal drainage
in the first 12 hours, and number and type of blood products
transfused in the postoperative period.
Data Analysis
Two outcomes were selected for analysis: (1) severe intraoperative
anemia, which was defined as the development of an intraoperative
hematocrit level of less than 19%, and (2) excessive postoperative
bleeding, which was defined as mediastinal drainage of greater
than 1000 mL in the first 12 hours postoperatively. Blood product
transfusions and re-exploration have been suggested as surrogates
for bleeding,9 but there is no consensus regarding the criteria for
transfusion2 or reoperation.19,20 These outcomes were also chosen
as potential outcomes that would be important triggers for trans-
fusion that would decrease, although not completely control, the
effect of variability in practice.
The postoperative period was defined as the time in the ICU up
to a maximum of 3 days for patients who stayed longer in the ICU.
The perioperative period was defined as the intraoperative and
postoperative periods combined. Patients having their procedure
performed off pump were analyzed separately.
Differences between patients who did or did not have the 2
major outcomes were tested for statistical significance by using the
Student t test for normally distributed data and the Wilcoxon rank
test for nonnormal continuous data, whereas 2 tests were used for
categorical variables. Multivariate logistic regression was per-
formed to obtain adjusted estimates of the odds with 95% confi-
dence intervals of patient, procedure, and provider factors associ-
ated with the development of intraoperative anemia and excessive
postoperative bleeding. Variables were included in the multivariate
models if they were significantly associated or if there was evi-
dence of a substantial effect on univariate analysis, as well as
clinical factors associated with transfusions in previous studies. A
nested model was used (PROC GENMOD-SAS) in which the
surgeons using the same intraoperative initial circuit volume and
similar type of antifibrinolytic agent were compared with each
other to assess the independent effect of surgeon. Statistical testing
was performed with SAS 8.2 (SAS Institute, Cary, NC).
Results
The preoperative variables of the 545 patients undergoing
CABG with extracorporeal circulation were similar among
the 3 hospitals (Table 1), and data from all 3 hospitals were
subsequently combined. The proportion of patients receiv-
ing aspirin and heparin preoperatively was significantly
different at the 3 sites, with corresponding differences in the
preoperative coagulation profile. Intraoperative pump time
and the number of grafts were also different. In hospital A,
which used larger circuit and HES volumes, significantly more
patients had severe intraoperative anemia, but fewer had ex-
cessive postoperative bleeding. Hospital C had the lowest
re-exploration rate, even though it had the highest proportion
of patients with excessive postoperative bleeding.
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were performed on pump had severe intraoperative anemia.
In univariate analysis this was significantly more likely in
older female patients and patients with a lower body surface
area and lower preoperative hemoglobin levels. Intraopera-
tive anemia was also associated with higher Parsonnet
scores or receipt of larger total volume and larger volumes
TABLE 1. Preoperative, intraoperative, and postoperative c
Hospital
No. of patients 214
Age, y (mean [SD]) 66.4 (10
Female sex, n (%) 48 (22
Body surface area (mean [SD]) 1.88 (0.
Parsonnet score (mean [SD]) 10.7 (9.
Patient with score 20, n (%) 30 (14
Medical history
Previous cardiac surgery, n (%) 8 (3.
Preop hematology
Hemoglobin (mean [SD]) 133.5 (15
Platelet count (mean [SD]) 246 (66
INR (mean [SD]) 1.07 (0.
PTT (mean [SD]) 45 (27
Preop medications
Heparin (full dose), n (%) 49 (23
Aspirin, n (%) 172 (81
Intraop variables
No. of grafts (mean [SD]) 3.1 (0.
Bypass time, min (mean [SD]) 77 (27
Tranexamic acid, n (%) 8 (4)
Aprotinin, n (%) 161 (76
No antifibrinolytic agent, n (%) 44
Pump volume added initially
Total 2000
Colloid 750
Postop variables
Platelet count (mean [SD]) 148 (60
INR (mean [SD]) 1.60 (0.
PTT (mean [SD]) 45 (13
Outcomes
Intraop HCT
Lowest (mean [SD]) 20.6 (4.
Patients with HCT 19%, n (%) 65 (30
Postop drainage in the first 12 h
Mean (SD) 765 (61
Patients bleeding 1 L, n (%) 42 (20
Patients transfused, n (%) 110 (51
Hemoglobin at ICU discharge (mean [SD]) 95 (13
Length of stay, d
In ICU (mean [median]) 2.2 (1)
Total in hospital (mean [median]) 9.5 (7)
Re-exploratory surgery, n (%) 8 (3.
Died, n (%) 4 (1.
SD, Standard deviation; NS, not significant; INR, international normalized rof colloid in the extracorporeal circuit (Table 2) but not with
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intraoperative anemia by surgeon varied from 18% to 49%
(Figure E1). Patients who had intraoperative anemia were
more likely to be transfused packed cells (Figure E2), had
lower ICU discharge hemoglobin levels, longer hospital and
ICU lengths of stay, and higher mortality; however, they did
not have an increased frequency of excessive postoperative
cteristics and outcomes of all patients in the 3 hospitals
Hospital B Hospital C P value
189 142
66.3 (10.2) 65.2 (9.6) NS
46 (24) 38 (27) NS
1.90 (0.21) 1.88 (0.28) NS
10.2 (8.6) 9.5 (6.9) NS
30 (16) 11 (8) .04
5 (2.6) 7 (5) NS
133.1 (15.6) 134.6 (18.5) NS
225 (73) 246 (73) .003
1.14 (0.31) 1.07 (0.16) .001
54 (39) 41 (29) .001
109 (58) 68 (48) .02
92 (49) 104 (73) .001
3.6 (1.1) 3.8 (1.1) .001
87 (32) 90 (35) .001
174 (92) 140 (99) .001
6 (3) 0
9 (5) 2 (1)
1400 1400
500 500
147 (62) 142 (54) NS
1.36 (0.24) 1.28 (0.28) .001
40 (23) 56 (41) .001
22.4 (3.5) 21.4 (4.0) .0001
32 (17) 34 (24) .006
800 (555) 965 (730) .01
47 (25) 50 (35) .005
89 (46) 83 (51) NS
100 (14) 100 (11) .001
3.2 (1) 2.2 (1) NS
11.7 (7) 10 (7) NS
14 (7.4) 2 (1.4) .008
7 (3.7) 6 (4.2) NS
TT, partial thromboplastin time; HCT, hematocrit; ICU, intensive care unit.hara
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formed off pump and therefore would not have received any
priming volumes, only 3 (4%) had intraoperative anemia
TABLE 2. Comparison of characteristics and outcomes be
erative hematocrit level of less than 19% in patients whos
No. of patients
Age, y (mean [SD])
Female sex, n (%)
Body surface area (mean [SD])
Parsonnet score (mean [SD])
Patient with score 20, n (%)
Medical history
Previous cardiac surgery, n (%)
LVEF 50%, n (%)
Preop hematology
Hemoglobin (mean [SD])
Platelet count (mean [SD])
INR (mean [SD])
PTT (mean [SD])
Preop medications
Heparin (full dose), n (%)
Aspirin, n (%)
Intraop variables
No. of grafts (mean [SD])
Bypass time, min (mean [SD])
Tranexamic acid, n (%)
Aprotinin, n (%)
No antifibrinolytic agent, n (%)
Pump volume added initially
Total (mean [SD])
Colloid (mean [SD])
Outcomes
Intraop transfusions of packed cells
No. of units transfused (mean [SD])
Patients transfused, n (%)
Postop drainage in first 12 h
Mean [SD]
Patients with 1 L drainage
Postop transfusions of packed cells, n (%)
No. of units transfused (mean [SD])
Patients transfused, n (%)
Total intraop and ICU postoperative transfusions
No. units transfused (mean [SD])
Patients transfused, n (%)
ICU discharge hemoglobin
Length of stay, d
ICU (mean [median])
Total in hospital (mean [median])
Re-exploratory surgery, n (%)
Died, n (%)
HCT, Hematocrit; RR, risk ratio; CI, confidence interval; SD, standard devia
PTT, partial thromboplastin time; ICU, intensive care unit.(data not shown).
The Journal of Thoracic aExcessive postoperative hemorrhage occurred in 26% of
the patients whose procedures were performed on pump.
The only preoperative patient characteristic associated with
n patients who did and did not have the lowest intraop-
ocedures were performed on pump
est intraop
T >19%
Lowest intraop
HCT <19%
RR (95% CI)
or P value
414 131
65 (10) 69.7 (9.6) .001
61 (15) 71 (31) 3.7 (2.8-4.9)
.93 (0.22) 1.75 (0.2) .001
9.3 (7.5) 13.2 (10.8) .001
41 (10) 31 (24) 2.0 (1.5-2.8)
12 (3) 8 (6) 2.1 (0.9-5.0)
17 (28) 36 (27) 1.0 (0.7-1.3)
7.2 (15.4) 122.5 (15.1) .001
35 (73) 250 (62) .01
1.1 (0.7) 1.1 (0.4) NS
47 (32) 47 (33) NS
75 (42) 51 (39) 0.9 (0.7-1.2)
75 (66) 93 (71) 1.2 (0.8-1.6)
3.5 (1.1) 3.4 (1.0) NS
82 (30) 89 (36) NS
53 (61) 69 (53) 0.8 (0.6-1.0)
23 (30) 44 (33) 1.1 (0.8-1.6)
38 (9) 18 (14) 1.4 (0.9-2.1)
14 (288) 1697 (301) .004
83 (463) 522 (477) .003
0.6 (1.4) 2.2 (2.6) .001
09 (26) 98 (75) 2.8 (2.1-3.8)
18 (629) 865 (640) NS
99 (24) 41 (31) 1.3 (1.0-1.8)
0.7 (1.8) 1.8 (3.0) .0001
97 (23) 74 (56) 2.8 (2.1-3.8)
1.4 (2.6) 4.0 (4.3) .0001
66 (40) 116 (88) 7.2 (4.3-12)
99 (13) 93 (13) .0001
2.4 (1) 3.4 (2) .007
9.9 (7) 12.1 (8) .003
16 (3.9) 8 (6.1) 1.6 (0.7-3.6)
9 (2.2) 8 (6.1) 2.8 (1.1-7.1)
LVEF, left ventricular ejection fraction; INR, international normalized ratio;twee
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more likely with longer bypass time, higher number of grafts
performed, and certain surgeons (Figure E3) and less likely if
aprotinin or tranexamic acid was used. Bleeding was not as-
TABLE 3. Comparison of characteristics and outcomes betw
drainage in the first 12 hours postoperatively in patients w
No. of patients
Age, y (mean [SD]) 6
Female sex, n (%)
Body surface area (mean [SD]) 1
Parsonnet score (mean [SD]) 1
Patients with score 20, n (%)
Medical history
Previous cardiac surgery, n (%)
LVEF 50%, n (%)
Preop hematology
Hemoglobin (mean [SD])
Platelet count (mean [SD])
INR (mean [SD])
PTT (mean [SD])
Preop medications
Heparin (full dose), n (%)
Aspirin, n (%)
Intraop variables
No. of grafts (mean [SD])
Bypass time, min (mean [SD])
Tranexamic acid, n (%)
Aprotinin, n (%)
No antifibrinolytic agent, n (%)
Lowest intraop HCT (mean [SD]) 2
Patients with intraop HCT 19%, n (%)
Transfused any packed cells in OR, n (%)
Mean no. of units transfused (mean [SD])
Postop variables
Platelet count (mean [SD])
INR (mean [SD])
PTT (mean [SD])
Outcomes
Postop transfusions of packed cells
No. of patients transfused, n (%)
No. of units transfused (mean [median])
Total intraop and ICU postop transfusions
No. of units transfused (mean [SD])
Patients transfused, n (%)
ICU discharge hemoglobin (mean [SD])
Length of stay, d
ICU (mean [median])
Total in hospital (mean [median]) 1
Re-exploratory surgery, n (%)
Died, n (%)
RR, Risk ratio; CI, confidence interval; SD, standard deviation; LVEF, left
thromboplastin time; HCT, hematocrit; OR, operating room; ICU, intensivesociated with preoperative aspirin or heparin or with coagula-
654.e5 The Journal of Thoracic and Cardiovascular Surgery ● Setion parameters measured immediately postoperatively. Pa-
tients with excessive postoperative bleeding were more likely
to be transfused packed cells (Figure E4), had longer ICU
lengths of stay, were more likely to undergo re-exploratory
patients who had less than or more than 1 L of mediastinal
e procedures were performed on pump
age
L
Drainage
>1 L
RR (95% CI) or
P value
5 140
0) 65.0 (10) NS
8) 20 (14) 0.5 (0.3-0.8)
.22) 1.89 (0.26) NS
.5) 9.7 (8.8) NS
3) 19 (14) 1.1 (0.6-1.7)
.7) 5 (3.5) 1.0 (0.4-2.6)
7) 44 (31) 1.2 (0.9-1.6)
6.2) 136 (17) .05
8) 245 (77) NS
.1) 1.1 (0.4) NS
0) 47 (37) NS
3) 52 (37) 0.8 (0.6-1.1)
7) 96 (68) 1.1 (0.8-1.4)
.1) 3.7 (1.0) .007
.7) 92 (39) .001
6) 92 (66) 1.4 (1.0-1.9)
5) 26 (19) 0.5 (0.4-0.8)
) 22 (15) 1.6 (1.1-2.3)
.0) 21.2 (4.1) NS
2) 41 (29) 1.3 (1.0-1.8)
4) 68 (48) 1.5 (1.2-2.0)
.2) 1.7 (2.9) .0001
8) 144 (63) NS
.3) 1.1 (0.1) NS
3) 47 (29) NS
2) 80 (57) 2.9 (2.2-3.9)
) 2.5 (1) .0001
.9) 4.2 (5.1) .0001
5) 101 (72) 3.0 (2.1-4.4)
3) 93 (12) .001
) 3.7 (2) .001
) 11.1 (7) NS
) 20 (14) 14.5 (5.0-42)
.5) 11 (8) 5.3 (2.0-14.1)
ricular ejection fraction; INR, international normalized ratio; PTT, partial
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performed off pump, a similar proportion to the population
with operations performed on pump, had excessive postop-
erative hemorrhage (data not shown).
In multivariate analysis (Table 4) of patients whose pro-
cedures were performed on pump, factors associated with
intraoperative anemia were those that might reflect greater
hemodilution, such as female sex, smaller body surface
area, lower preoperative hemoglobin level, and larger initial
total and colloid volume in the bypass circuit.
None of these factors were associated with postoperative
bleeding. In contrast, excessive postoperative hemorrhage
was associated with male sex and was less likely in patients
who received aprotinin. After adjusting for these factors,
certain surgeons had significantly higher rates of postoper-
ative bleeding. When multivariate linear analyses were per-
formed evaluating blood loss and lowest intraoperative ane-
mia as continuous variables, the same factors were
significantly associated as were associated with the exces-
sive postoperative hemorrhage and severe intraoperative
anemia as defined dichotomously.
Severe intraoperative anemia was a stronger predictor of
packed cell transfusions, whereas excessive postoperative
TABLE 4. Multivariate analysis of factors associated wi
postoperative bleeding in patients whose procedures wer
Characteristics
Low
adju
Older age (increase of 5 [eg, 65-70])
Female sex
Lower preoperative hemoglobin (decrease of 10)
Lower body surface area (decrease of 0.1)
Longer bypass time (increase of 30 min)
Heparin
Aspirin
Aprotinin
Tranexamic acid
High pump volume†
Surgeons‡
Group 1
Surgeon 1
Surgeon 2
Surgeon 3
Surgeon 4
Group 2
Surgeon 5
Surgeon 6
Surgeon 7
Surgeon 8
HCT, Hematocrit; CI, confidence interval. *Bold values indicate significan
priming volume. ‡Surgeons compared only with other surgeons using
extracorporeal circulation and antifibrinolytic agent: group 1, 750 mL penta
of total of 1400 mL of priming solution.hemorrhage was a stronger predictor of receiving coagula-
The Journal of Thoracic ation factors. Of the patients who had severe intraoperative
anemia, 88% were transfused packed cells perioperatively
compared with 72% who had excessive postoperative hem-
orrhage, whereas of the patients who met the criteria for
excessive postoperative hemorrhage, 50% received fresh
frozen plasma and 33% received platelets compared with
only 27% receiving fresh frozen plasma and 17% receiving
platelets among the patients with intraoperative anemia
(Table 5).
Discussion
We have shown that intraoperative anemia and excessive
bleeding were associated with different risk factors and appear
to be independent phenomena. Both were common and asso-
ciated with worse outcomes and increased blood product trans-
fusion. Some of the risk factors found are potentially modifi-
able, which suggests that efforts could be undertaken to
decrease the frequency of these 2 entities and thereby possibly
improve outcomes in patients undergoing CABG.
One important inference from these results is that peri-
operative blood product requirements in cardiac surgery
might not all be due to excessive bleeding. Patients who had
intraoperative anemia had the same mean volume of medi-
e development of intraoperative anemia and excessive
rformed on pump*
ntraop HCT <19%,
odds ratio (95% CI)
Mediastinal drainage >1 L in the first
12 postop hours, odds ratio (95% CI)
1 (0.9-1.2) 0.9 (0.8-1.0)
7 (2.1-6.5) 0.4 (0.2-0.7)
6 (1.4-1.9) 0.9 (0.8-1.05)
2 (1.1-1.4) 0.9 (0.8-1.0)
4 (1.1-1.8) 1.6 (1.3-2.0)
7 (0.4-1.2) 0.8 (0.5-1.3)
3 (0.7-2.3) 1.1 (0.5-1.8)
6 (0.3-1.4) 0.2 (0.1-0.7)
9 (0.3-7.9) 0.6 (0.2-1.6)
5 (3.2-73) 0.5 (0.1-2.6)
0 (reference) 1.0 (reference)
7 (0.2-1.9) 6.9 (1.6-30)
5 (0.2-1.5) 5.3 (1.3-21)
5 (0.2-1.4) 8.7 (2.1-36)
0 (reference) 1.0 (reference)
0 (0.8-5.4) 3.3 (1.5-7.4)
4 (0.5-3.7) 4.4 (2.0-9.7)
2 (0.7-6.4) 2.8 (1.2-6.8)
ociations, P  .05. †High pump volume: 750 pentastarch of total of 2000
r institutional practices of initial volume of fluid and colloid added to
h of a total of 2000 mL of priming volume; group 2, 500 mL of pentastarchth th
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excessive postoperative bleeding. Many patients who had
intraoperative anemia in this study received a transfusion
both in the operating room and postoperatively.21,22 The
differences in the use of coagulation factors associated with
mediastinal drainage compared with severe intraoperative
anemia also support the hypothesis that clinicians are re-
sponding differently to the 2 transfusion triggers.
In this study the strong association of intraoperative
anemia with female sex, lower preoperative hemoglobin
level, smaller body surface area, and larger total and colloid
volume in the initial pump priming solution suggests that
hemodilution was an important contributor to this problem.
This is also supported by the almost negligible risk (4%) in
patients undergoing off-pump procedures. The occurrence
of intraoperative anemia has been shown to be an indepen-
dent predictor of perioperative mortality and morbidity,4,6
and strategies to decrease its occurrence might improve
outcomes in this population. These strategies would include
first decreasing preoperative anemia with practices such as
limiting preoperative23 blood taking, use of more micro-
laboratory techniques, and iron supplementation and per-
haps erythropoietin in patients awaiting elective operations.
Second, because of the strong association with the larger
volumes of priming solution with higher volumes of colloid
in the extracorporeal circuit, the volume should be adjusted,
taking into consideration patient size, sex, and preoperative
hemoglobin concentration, rather than using a fixed volume.
This is supported by previous reports24,25 of decreases in
intraoperative packed cell use with the use of lower prime
volume. In a recent study,26 use of hetastarch increased the
likelihood of patients undergoing coronary artery surgery
receiving 3 or more units of any blood product. The
hetastarch might have contributed to greater hemodilution
and lower intraoperative hematocrit levels, as well as in-
creased bleeding.26 In our study, higher pump volumes and
use of more colloid was strongly associated with intraoper-
ative anemia but not with excessive postoperative bleeding.
In the study hospitals, the medium-molecular-weight starches
(Pentaspan; Bristol Myers Squibb Canada), for which there are
TABLE 5. Comparison of different blood product use in pati
levels of less than 19 g/L or mediastinal drainage of great
Periop blood products
Lowest intraop HCT <19%
vs >19%, RR (95% CI)
No. of patients 131
Packed cells 7.2 (4.3-12)
Fresh frozen plasma 1.6 (1.2-2.2)
Platelets 1.4 (0.9-2.0)
HCT, Hematocrit; RR, risk ratio; CI, confidence interval.less data on increased bleeding risk, are used.27 The doses of
654.e7 The Journal of Thoracic and Cardiovascular Surgery ● Sehetastarch used during bypass were fixed and in most patients
were less than 15 mL/kg.
Although excessive postoperative hemorrhage has been
reported to be one of the most common complications of
cardiac surgery,12 relatively few studies have examined this
outcome11,28 because most studies examined perioperative
transfusions. It has been suggested that outcomes related to
excessive drainage should be examined, such as resternot-
omy29 and blood product transfusions; our results highlight
the limitations of this approach. We noted marked differ-
ences in reoperation rates and blood product use in the 3
study sites, which were not related to rates of postoperative
bleeding (Table 1) but might reflect practice differences.
Therefore, analysis of factors associated with the amount of
postoperative bleeding was less likely to be biased than
analysis of factors associated with these management deci-
sions. In addition, because postoperative bleeding was as-
sociated with longer ICU lengths of stay, transfusions, and
a higher mortality, we believe this definition is clinically
relevant. In addition, measurement of postoperative medi-
astinal drainage is objective, routinely performed, and
reproducible.
In a prospective study of more than 10,000 patients under-
going cardiac surgery, patient characteristics were not associ-
ated with reoperation for postoperative bleeding.30 The authors
suggested that reoperation for bleeding might be more related
to technical surgical factors rather than patient-related factors.
Two other studies have demonstrated that postoperative hem-
orrhage was associated with surgeon,11,13 and meticulous sur-
gical technique is frequently mentioned16 as an important
means to decrease blood product use in cardiac surgery. These
findings are consistent with ours, in which male sex was the
only patient characteristic and surgeon was strongly associated
with this outcome. We speculated that the association with
male sex might have occurred because of the assumption that
female subjects have higher bleeding risks, which might have
resulted in more meticulous surgical practices in female subjects.
We attempted to include in the multivariate analysis the
important factors believed to be associated with increased
risk of bleeding and transfusion requirements, as well as the
undergoing CABG on pump with intraoperative hematocrit
an 1 L
Mediastinal drainage >1 L
vs <1 L in the first 12 h,
RR (95% CI)
Anemia vs bleeding,
RR (95% CI)
140
3.0 (2.1-4.4) 2.8 (1.5-5.3)
4.4 (3.5-5.7) 0.6 (0.4-0.9)
3.3 (2.6-4.3) 0.6 (0.4-0.8)ents
er thfactors that differed among the 3 hospitals. There might be
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Dial et al Cardiopulmonary Support and Physiologyother unmeasured factors that we did not account for that
could explain some of the results. Certain variables were also
very tightly correlated, such as antifibrinolytic use, volume of
prime used in the extracorporeal circuit, and particular surgeon,
which limit some of the inferences that can be drawn from the
results. In this study neither larger total circuit volumes nor
larger HES volumes were associated with excessive mediasti-
nal drainage. Although there have been recommendations that
HES not be used in patients undergoing cardiac surgery be-
cause of concerns of excess bleeding, we did not find that
association in this study, even after adjusting for many clinical
variables. The almost exclusive use of aprotinin by the center
using the larger volumes of HES might account for our not
finding an effect.
There were very few patients who had been exposed
to clopidogrel, and no patient had been prescribed low-
molecular-weight heparin. We also studied only patients
who had bypass procedures alone, without any valvular
procedures, and therefore the conclusions might not be
applicable to these patient populations. Although repeat
surgical interventions were not associated with an increased
risk of bleeding in this study, the study might have been
underpowered to evaluate this association.
Conclusions
Our results suggest that many factors contribute to triggers
to blood product transfusion in cardiac surgery. Reducing
these triggers requires different strategies, including meth-
ods to decrease hemodilution, especially in small female
subjects who might have anemia before surgical interven-
tion. This could include identification and treatment of
preoperative anemia and re-evaluation of the design of the
bypass circuit. Adjustment of prime volumes with less HES
use and use of techniques such as retrograde autologous
prime might also be beneficial. On the other hand, postop-
erative bleeding can be reduced with the use of aprotinin.
However, given the association of surgeon with this out-
come in this study, meticulous surgical technique appears to
be critical to decreasing excessive postoperative bleeding.
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